Protagonist Therapeutics, Inc.PTGXNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+8.1%
5Y CAGR+16.0%
Year-over-Year Change
Research and development spending
3Y CAGR
+8.1%/yr
vs +20.7%/yr prior
5Y CAGR
+16.0%/yr
Recent deceleration
Acceleration
-12.6pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.1x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $159.29M | +15.3% |
| 2024 | $138.13M | +15.0% |
| 2023 | $120.16M | -4.8% |
| 2022 | $126.22M | +0.2% |
| 2021 | $126.01M | +65.8% |
| 2020 | $75.98M | +16.9% |
| 2019 | $65.00M | +9.3% |
| 2018 | $59.50M | +28.8% |
| 2017 | $46.18M | +79.7% |
| 2016 | $25.70M | - |